Revelation Biosciences REVB
NASDAQ REVB
$0.83 -0.03 (-3.64%)
As of: Sep 29, 2026 · 3:59 PM EDT

Revelation Biosciences (REVB) Total Current Liabilities (2020 - 2026)

Updated

Revelation Biosciences (REVB) reported Total Current Liabilities of $1.88 million for Q2 2026, up 19.8% from $1.57 million a year earlier and up 32.7% from the prior quarter.

Analysis

Revelation Biosciences (REVB) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Revelation Biosciences posted Total Current Liabilities of $2 million, up 4.4% from FY2024.

  • Total Current Liabilities has a five-year compound annual growth rate of -10.3% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $1.91 million in FY2024 (-65.6%), $5.56 million in FY2023 (+25.0%), $4.45 million in FY2022 (+107.8%) and $2.14 million in FY2021 (-37.6%).
  • Five-year quarterly Total Current Liabilities spans a low of $1.09 million in Q1 2025 and a high of $11.13 million in Q2 2024.
  • Year over year, Total Current Liabilities has now increased in each of the last three quarters, with an average decline of 31.9% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q1 2022 (growth of 280.9%); the low point was Q2 2025 (a decline of 85.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.42 million (Q1 2026), $2 million (Q4 2025) and $1.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Revelation Biosciences 3.36 Mn -45.66 Mn - 1.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.88 Mn
Mar 31, 2026 1.42 Mn
Dec 31, 2025 2.00 Mn
Sep 30, 2025 1.85 Mn
Jun 30, 2025 1.57 Mn
Mar 31, 2025 1.09 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 4.07 Mn
Jun 30, 2024 11.13 Mn
Mar 31, 2024 5.23 Mn
Dec 31, 2023 5.56 Mn
Sep 30, 2023 5.40 Mn
Jun 30, 2023 4.62 Mn
Mar 31, 2023 8.10 Mn
Dec 31, 2022 4.45 Mn
Sep 30, 2022 4.37 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 8.08 Mn
Dec 31, 2021 2.14 Mn
Sep 30, 2021 3.74 Mn
API Access

Revelation Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=REVB&period=max&api_key=YOUR_API_KEY